Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across ...
Research study: Palatinus HN, Johnson MA, Wang HE, Hoareau GL, Youngquist ST. Early intramuscular adrenaline administration ...
BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not ...
Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...
Survival analysis is a branch of statistics that examines the expected duration until one or more events occur, such as death or failure. Traditionally applied in medical research and reliability ...
Clinical validation of different HRD assays in high-grade serous ovarian cancer in Greek population. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study This is a single-institution ...
MedPage Today on MSN
Practice-Influencing Results in Oligometastatic Prostate Cancer
Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...
High intake of the popular beverages appears to be be associated with a 24 percent reduction in cancer progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results